Form 8-K - Current report:
SEC Accession No. 0001415889-11-001366
Filing Date
2011-12-07
Accepted
2011-12-07 14:24:11
Documents
3
Period of Report
2011-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-12072011_111200.htm 8-K 15345
2 ex10-12072011_111202.htm EX-10 48873
3 ex99-12072011_111211.htm EX-99 12781
  Complete submission text file 0001415889-11-001366.txt   78280
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54014 | Film No.: 111248156
SIC: 2834 Pharmaceutical Preparations